Search Results - "Amosenko, F A"

K-ras, BRCA1/2, and CHEK2 mutations and loss of heterozygosity at 9p, 17p, and 18q in sporadic adenocarcinoma of the pancreas by Amosenko, F. A., Kazubskaya, T. P., Gromyko, O. E., Matveeva, T. I., Korchagina, E. L., Nasedkina, T. V., Garkavtseva, R. F., Kalinin, V. N.

“…The diagnostic significance of molecular markers was assessed for the most common somatic aberrations at the K-ras, TP53, CDKN2A , and MADH4 loci, as well as…”
Get full text

Mutation analysis of K-ras protooncogene in colorectal adenocarcinomas and polyps in Russian patients by Amosenko, F. A, Korchagina, E. L, Matveeva, T. I, Vaganov, Yu. E, Vlasov, S. B, Poltavets, N. V, Veselov, V. V, Garkavtseva, R. F, Polyakov, A. V

“…To estimate diagnostic value of K-ras mutations during cancer risk group formation, they were studied in the samples of sporadic carcinomas (n = 58), benign (n…”
Get full text

Comparison of different methods of molecular-genetic analysis of somatic mutations in K-ras gene in patients with colorectal cancer by Amosenko, F A, Karpov, I V, Poliakov, A V, Kovalenko, S P, Shamanin, V A, Liubchenko, L N

“…Two approaches to somatic point mutations in 12 and 13 codones of K-ras gene were analyzed: PCR/SSCP/ACRS/sequencing and allele-specific PCR in the real-life…”
Get more information

Analysis of K-ras, BRCA1/2, CHEK2 mutations and microsatellite markers (loss of heterozygosity at 9p, 17p and 18q) in sporadic pancreas adenocarcinomas by Amosenko, F A, Kazubskaia, T P, Gromyko, O E, Matveeva, T I, Korchagina, E L, Nasedkina, T V, Gar'kavtseva, R F, Kalinin, V N

“…The purpose of this study was to investigate informativety and clinical significance of most frequent somatic alterations in K-ras, TP53, CDKN2A, MADH4 and…”
Get more information

Biochip analysis of BRCA1/2 and CHEK2 common mutations in ovarian cancer and primary multiple tumors involving the ovaries (Russian population) by Fedorova, O. E., Lyubchenko, L. N., Payanidi, Yu. G., Kazubskaya, T. P., Amosenko, F. A., Garkavtseva, R. F., Zasedatelev, A. S., Nasedkina, T. V.

“…Ovarian cancer (OC) is among the leading causes of cancer-related mortality in women. A high risk of OC (lifetime estimates ranging 10-60%) is determined by…”
Get full text

Use of protamine sulphate for elimination of substrate DNA in poliovaccines produced on continuous cell lines by Amosenko, F A, Svitkin, Y V, Popova, V D, Terletskaya, E N, Timofeev, A V, Elbert, L B, Lashkevich, V A, Drozdov, S G

“…Cell substrate DNA was shown to be an abundant contaminant in the clarified preparations of the Sabin type 1, 2 and 3 poliovaccines produced on a continuous…”
Get more information

Analysis of BRCA1/2 and CHEK2 mutations in ovarian cancer and primary multiple tumors involving the ovaries. Patients of Russian population using biochips by Fedorova, O E, Liubchenko, L N, Paiadini, Iu G, Kazubskaia, T P, Amosenko, F A, Gar'kavtseva, R F, Zasedatelev, A S, Nasedkina, T V

“…Ovarian cancer (OC) is one of the leading cause of cancer death in women. Inherited BRCA1 and BRCA2 mutations strikingly increase OC risk (with lifetime risk…”
Get more information

Three novel mutations in the RET proto-oncogene by Kalinin, V N, Amosenko, F A, Shabanov, M A, Lubchenko, L N, Hosch, S B, Garkavtseva, R F, Izbicki, J R

“…Medullary thyroid carcinoma (MTC) occurs as a sporadic tumor or in connection with inherited cancer syndromes of multiple endocrine neoplasia type 2 and…”
Get full text

Inactivated vaccine against tick-borne encephalitis (TBE) derived from heteroploid continuous monkey cell line by Elbert, L B, Terletskay, E N, Timofeev, A V, Mironova, L L, Khapchaev, U K, Amosenko, F A, Svitkin, Y V, Alpatova, G A, Krutyanskaya, G L

Get more information

MEDULLARY THYROID CANCER AS PART OF MEN 2B SYNDROME. CASE REPORT by L. N. Lyubchenko, F. A. Amosenko, M. G. Filippova, V. Z. Dobrokhotova, E. G. Matyakin

“…MEN 2B syndrome is a subtype of the multiple endocrine neoplasia type 2. It is characterized by the development of aggressive forms of medullary thyroid cancer…”
Get full text

Detection of KRAS mutations in tumor cells using biochips by Emel'ianova, M A, Amosenko, F A, Chudinov, A V, Surzhikov, S A, Kazubskaia, T P, Liubchenko, L N, Nasedkina, T V

“…Somatic mutations in the KRAS gene are important markers of some types of tumors, for example, pancreatic cancer, and may be useful in early diagnostics. A…”
Get more information

TUB9 polymorphism in the CFTR gene of cystic fibrosis patients, carriers, and healthy donors from the Moscow region. SSCP and restriction analyses by Amosenko, F A, Trubnikova, I S, Zakhar'ev, V M, Bannikov, V M, Sazonova, M A, Petrova, N V, Kapranov, N I, Kaplinin, V N

“…Data on the screening of 266 non-delta F508 chromosomes (42 cystic fibrosis patients, 43 carriers, and 48 healthy donors from the Moscow region) for the…”
Get more information

Mutation analysis of K-ras protooncogene in colorectal adenocarcinomas and polyps in Russian patients by Amosenko, F A, Korchagina, E L, Matveeva, T I, Vaganov, Iu E, Vlasov, S B, Poltavets, N V, Veselov, V V, Gar'kavtseva, R F, Poliakov, A V

“…To estimate diagnostic value of K-ras mutations during cancer risk group formation, they were studied in the samples of sporadic carcinomas (n = 33) and…”
Get more information

Analysis of mutations in the RET proto-oncogene in patients with medullary thyroid tumor by Amosenko, F A, Brzhezovskiĭ, V Zh, Liubchenko, L N, Shabanov, M A, Kozlova, V M, Vanushko, V E, Kazubskaia, T P, Gar'kavtseva, R F, Kalinin, V N

“…The spectrum of mutations of the RET protooncogene was analyzed in Russian patients with inherited or sporadic medullary thyroid carcinoma (MTC). Four RET…”
Get more information

Molecular diagnosis of multiple type 2 endocrine neoplasia by Amosenko, F A, Pushkash, K, Frilling, A, Kozlova, V N, Liubchenko, L N, Kazubskaia, T P, Brelysh, K E, Gar'kavtseva, R F, Kalinin, V N

“…The paper reviews the data on the molecular structure of the protooncogene RET encoding for receptor-type protein kinase, on the mechanism of transformation of…”
Get more information

Molecular genetic analysis of TUB18 and TUB20 intragenic polymorphism and various mutations of the CFTR gene in the Moscow region by Sazonova, M A, Amosenko, F A, Kapranov, N I, Kalinin, V N

“…Allelic frequencies of two intron polymorphisms in the cystic fibrosis transmembrane regulator (CFTR) gene, TUB18 and TUB20, were estimated on chromosomes of…”
Get more information

Three novel mutations in the RET proto-oncogene by KALININ, V. N, AMOSENKO, F. A, SHABANOV, M. A, LUBCHENKO, L. N, HOSCH, S. B, GARKAVTSEVA, R. F, IZBICKI, J. R

Get full text

A new inherited RET proto-oncogene mutation associated with familial medullary thyroid carcinoma and polymorphisms in adjacent regions by Kalinin, V N, Amosenko, F A, Puskas, C, Frilling, A, Broelsch, C E, Pushkash, K, Brel'sh, K E

“…A new point mutation, TCG(Ser)-->GCG(Ala) in codon 891, exon 15 of the RET protooncogene was revealed in two patients from a pedigree with familial medullary…”
Get more information

Analysis of various polymorphic markers of the CFTR gene in cystic fibrosis patients and healthy donors from the Moscow region by Amosenko, F A, Sazonova, M A, Kapranov, N I, Trubnikova, I S, Kalinin, V N

“…Allelic frequencies at three polymorphic markers in the CFTR gene were detected on chromosomes derived from cystic fibrosis (CF) patients and healthy donors…”
Get more information

The purification of tick-borne encephalitis virus preparations of cellular DNA by El'bert, L B, Terletskaia, E N, Timofeev, A V, Amosenko, F A, Khapchaev, Iu Kh, Mironova, L L, Svitkin, Iu V, Vorovich, M F, Lisitsyna, E A

“…According to the WHO requirements, the concentration of cellular DNA in vaccine preparations produced by pooling virus from continuous cell lines is limited to…”
Get more information